Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

Peter A. Campochiaro, Robert L. Avery, David M. Brown, Jeffrey S. Heier, Allen C. Ho, Stephen Huddleston, Glenn J. Jaffe, Arshad M. Khanani, Stephen Pakola, Dante J. Pieramici, Charles C. Wykoff, Sherri Van Everen